Latest Breaking News On - Natural killer cell - Page 3 : comparemela.com

Geneius Biotechnology Announces Poster Presentation at the 2023 AACR Annual Meeting

Medigene to present first pre-clinical data for MDG1015 with poster presentation at AACR 2023 Annual Meeting

Medigene to present first pre-clinical data for MDG1015

Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the.

Sanofi to license Innate Pharma's NK cell platform

Sanofi will license Innate Pharma’s B7H3 ANKET platform, which is creating a new class of molecules to induce synthetic cancer immunity.

GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022

Presentation shows the therapeutic potential of combining iPSC-derived CAR NK cells and NK cell engagers to overcome the clinical heterogeneity of AML